USANA Health Sciences ROA 2012-2026 | USNA

Current and historical return on assets (ROA) values for USANA Health Sciences (USNA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2026-03-31 $0.01B $0.74B 1.22%
2025-12-31 $0.01B $0.74B 1.36%
2025-09-30 $0.02B $0.74B 2.16%
2025-06-30 $0.03B $0.73B 4.69%
2025-03-31 $0.03B $0.70B 4.86%
2024-12-31 $0.04B $0.67B 6.27%
2024-09-30 $0.06B $0.64B 8.58%
2024-06-30 $0.06B $0.62B 8.82%
2024-03-31 $0.06B $0.62B 10.06%
2023-12-31 $0.06B $0.61B 10.32%
2023-09-30 $0.06B $0.60B 9.80%
2023-06-30 $0.06B $0.59B 10.67%
2023-03-31 $0.07B $0.58B 11.22%
2022-12-31 $0.07B $0.57B 12.08%
2022-09-30 $0.08B $0.57B 13.42%
2022-06-30 $0.09B $0.57B 15.38%
2022-03-31 $0.11B $0.58B 18.44%
2021-12-31 $0.12B $0.58B 19.89%
2021-09-30 $0.14B $0.60B 22.70%
2021-06-30 $0.14B $0.60B 23.38%
2021-03-31 $0.13B $0.58B 22.45%
2020-12-31 $0.13B $0.55B 22.86%
2020-09-30 $0.12B $0.52B 22.49%
2020-06-30 $0.11B $0.49B 22.38%
2020-03-31 $0.10B $0.50B 20.75%
2019-12-31 $0.10B $0.52B 19.38%
2019-09-30 $0.10B $0.53B 19.23%
2019-06-30 $0.11B $0.56B 19.31%
2019-03-31 $0.12B $0.57B 21.23%
2018-12-31 $0.13B $0.57B 22.16%
2018-09-30 $0.09B $0.56B 15.72%
2018-06-30 $0.08B $0.53B 15.20%
2018-03-31 $0.07B $0.52B 13.46%
2017-12-31 $0.06B $0.50B 12.36%
2017-09-30 $0.09B $0.49B 18.38%
2017-06-30 $0.10B $0.48B 20.08%
2017-03-31 $0.10B $0.45B 22.04%
2016-12-31 $0.10B $0.44B 22.77%
2016-09-30 $0.10B $0.43B 23.87%
2016-06-30 $0.10B $0.43B 23.00%
2016-03-31 $0.10B $0.43B 22.78%
2015-12-31 $0.10B $0.41B 23.09%
2015-09-30 $0.09B $0.39B 23.38%
2015-06-30 $0.09B $0.36B 23.42%
2015-03-31 $0.08B $0.35B 22.60%
2014-12-31 $0.08B $0.35B 21.81%
2014-09-30 $0.08B $0.35B 21.26%
2014-06-30 $0.07B $0.36B 20.49%
2014-03-31 $0.08B $0.34B 22.79%
2013-12-31 $0.08B $0.32B 24.94%
2013-09-30 $0.08B $0.29B 26.42%
2013-06-30 $0.08B $0.28B 27.77%
2013-03-31 $0.07B $0.27B 26.14%
2012-12-31 $0.07B $0.27B 24.74%
2012-09-30 $0.06B $0.26B 23.37%
2012-06-30 $0.06B $0.25B 22.42%
2012-03-31 $0.05B $0.24B 22.46%
2011-12-31 $0.05B $0.22B 22.57%
2011-09-30 $0.05B $0.22B 22.82%
2011-06-30 $0.05B $0.21B 24.04%
2011-03-31 $0.05B $0.19B 24.42%
2010-12-31 $0.05B $0.17B 26.47%
2010-09-30 $0.04B $0.15B 29.28%
2010-06-30 $0.04B $0.13B 30.00%
2010-03-31 $0.04B $0.12B 29.84%
2009-12-31 $0.03B $0.12B 28.10%
2009-09-30 $0.03B $0.12B 23.14%
2009-06-30 $0.03B $0.12B 23.14%
2009-03-31 $0.03B $0.12B 24.17%
2008-12-31 $0.03B $0.12B 24.27%
2008-09-30 $0.04B $0.12B 31.03%
2008-06-30 $0.04B $0.11B 35.06%
2008-03-31 $0.04B $0.11B 37.65%
2007-12-31 $0.05B $0.11B 43.06%
2007-09-30 $0.04B $0.10B 43.03%
2007-06-30 $0.04B $0.10B 43.65%
2007-03-31 $0.04B $0.09B 45.65%
2006-12-31 $0.04B $0.09B 46.38%
2006-09-30 $0.04B $0.08B 50.16%
2006-06-30 $0.04B $0.08B 48.93%
2006-03-31 $0.04B $0.09B 47.20%
2005-12-31 $0.04B $0.08B 46.43%
2005-09-30 $0.04B $0.08B 45.51%
2005-06-30 $0.04B $0.08B 45.86%
2005-03-31 $0.03B $0.07B 44.44%
2004-12-31 $0.03B $0.07B 43.32%
2004-09-30 $0.03B $0.07B 41.48%
2004-06-30 $0.03B $0.06B 41.94%
2004-03-31 $0.02B $0.06B 39.83%
2003-12-31 $0.02B $0.05B 41.18%
2003-09-30 $0.02B $0.05B 38.20%
2003-06-30 $0.01B $0.04B 32.10%
2003-03-31 $0.01B $0.04B 29.33%
2002-12-31 $0.01B $0.04B 21.62%
2002-09-30 $0.01B $0.04B 16.67%
2002-06-30 $0.01B $0.04B 13.79%
2002-03-31 $0.00B $0.04B 8.16%
2001-12-31 $0.00B $0.04B 5.52%
2001-09-30 $0.00B $0.04B 5.52%
2001-06-30 $0.00B $0.04B 2.72%
2001-03-31 $0.00B $0.04B 2.70%
2000-12-31 $0.00B $0.04B 5.23%
2000-09-30 $0.00B $0.04B 7.74%
2000-06-30 $0.00B $0.04B 5.19%
2000-03-31 $0.00B $0.04B 10.32%
1999-12-31 $0.01B $0.04B 12.74%
1999-09-30 $0.01B $0.04B 15.00%
1999-06-30 $0.01B $0.04B 25.32%
1999-03-31 $0.01B $0.04B 26.32%
1998-12-31 $0.01B $0.04B 27.97%
1998-09-30 $0.01B $0.03B 27.91%
1998-06-30 $0.01B $0.03B 27.59%
1998-03-31 $0.01B $0.03B 31.07%
1997-12-31 $0.01B $0.02B 30.77%
1997-09-30 $0.01B $0.02B 27.91%
1997-06-30 $0.01B $0.02B 25.00%
1997-03-31 $0.00B $0.02B 21.62%
1996-12-31 $0.00B $0.02B 24.62%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.334B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00